Get started
Award

82060427

Funded outputs count: 16
Funder award ID: 82060427
OpenAlex ID: G4124536070
Bidirectional Mendelian randomization study shows causal relationship between high- altitude adaptation and liver diseases
2024 · Tianzhun Wu, Ruofan Li, et al. · Research Square
PDF
999P Donafenib combined with hepatic artery infusion chemotherapy (HAIC) and sintilimab for unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II trial (DoHAICs study)
2023 · W. Zhang, W. Gao, et al. · Annals of Oncology · 3
PDF
997P A practical risk classification of early recurrence and long term survival outcomes in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy: A decision tree analysis
2023 · R.Y. Mai, R. Liang, et al. · Annals of Oncology
PDF
996P Transarterial chemoembolization combined donafenib with/without programmed death-1 inhibitors for initially unresectable hepatocellular carcinoma in a multicenter retrospective study
2023 · X. Duan, H. Li, et al. · Annals of Oncology · 1
PDF
1000P Real-world clinical outcomes of cabozantinib (cabo) as a second-line (2L) treatment for advanced hepatocellular carcinoma (aHCC)
2023 · D. Ahn, N.J. Park, et al. · Annals of Oncology · 1
PDF
A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma
2023 · Julu Huang, Rong Liang, et al. · International Journal of Molecular Sciences · 1
PDF
Progress of research on molecular targeted therapies for colorectal cancer
2023 · Shilin Huang, Jiazhou Ye, et al. · Frontiers in Pharmacology · 13
PDF
Prognosis-Related Molecular Subtypes and Immune Features Associated with Hepatocellular Carcinoma
2022 · Jiazhou Ye, Yan Lin, et al. · Cancers · 12
PDF
Cleavage of tropomodulin-3 by asparagine endopeptidase promotes cancer malignancy by actin remodeling and SND1/RhoA signaling
2022 · Binghong Chen, Mengying Wang, et al. · Journal of Experimental & Clinical Cancer Research · 22
PDF
Prognosis-related molecular subtypes and immune features associated with hepatocellular carcinoma
2022 · Jiazhou Ye, Yan Lin, et al. · Research Square
PDF
A novel molecular subtype of hepatocellular carcinoma based on the tumor purity and tumor microenvironment-related polygenic risk scores
2022 · Yan Lin, Rong Liang, et al. · medRxiv
PDF
Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma
2022 · Yan Lin, Ziqin He, et al. · Oxidative Medicine and Cellular Longevity · 5
PDF
Eukaryotic Initiation Factor 4A-3: A Review of Its Physiological Role and Involvement in Oncogenesis
2021 · Jiazhou Ye, Xiaomin She, et al. · Frontiers in Oncology · 63
PDF
Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma
2021 · Rong Liang, Jinyan Zhang, et al. · Frontiers in Oncology · 20
PDF
Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer
2020 · Yan Lin, Ziqin He, et al. · OncoTargets and Therapy · 147
PDF
RNA-Binding Motif Protein 38 as a Potential Biomarker and Therapeutic Target in Cancer
2020 · Xiaomin She, Yan Lin, et al. · OncoTargets and Therapy · 15
PDF
Year
Topic